Treatment Of Depression Disorder Essay Discussion Paper

Treatment Of Depression Disorder Essay Discussion Paper

Need Help Writing an Essay?

Tell us about your assignment and we will find the best writer for your paper

Write My Essay For Me

For this assignment, you will develop a patient medication guide for treatment of depressive disorders in a vulnerable population (your choice for one vulnerable patient population to choose from: children, adolescents, older adults, dementia patients, pregnant women or one not listed of your choice!). Be sure to use language appropriate for your audience (patient, caregiver, parent, etc.). You will include non-copyright images and/or information tables to make your patient medication guide interesting and appealing. Limit your patient medication guide to 5 pages. You will create this guide as an assignment; therefore, a title page, introduction, conclusion, and reference page are required. You must include a minimum of 3 scholarly supporting resources outside of your course provided resources.

In your patient guide, include discussion on the following:

Depressive disorder causes and symptoms
How depression is diagnosed for the vulnerable population of your choice, why is this population considered vulnerable
Medication treatment options including risk vs benefits; side effects; FDA approvals for the vulnerable population of your choice
Medication considerations of medication examples prescribed (see last bullet item)
What is important to monitor in terms of labs, comorbid medical issues with why important for monitoring
Special Considerations (you must be specific, not general and address at least one for EACH category; you must demonstrate critical thinking beyond basics of HIPPA and informed consent!): legal considerations, ethical considerations, cultural considerations, social determinants of health
Where to follow up in your local community for further information
Provide 3 examples of how to write a proper prescription that you would provide to the patient or transmit to the pharmacy.

ORDER A PLAGIARISM-FREE PAPER HERE

Depression is a common mental health disorder that affects millions of people worldwide. However, it can be especially challenging for pregnant women, who are already vulnerable due to the physical and emotional changes that come with pregnancy. Medication can be an effective treatment for depressive disorders, but it is essential to understand the risks and benefits, as well as any special considerations that apply to this population. This patient medication guide aims to provide valuable information on depressive disorders and medication treatment options for pregnant women Treatment Of Depression Disorder Essay Discussion Paper.

Depression can affect anyone, regardless of age, gender, or background. However, pregnant women are considered a vulnerable population for several reasons. Hormonal changes, stress, and social and cultural factors can all contribute to the development of depressive disorders during pregnancy. In addition, depression during pregnancy can have serious consequences for both the mother and the baby, including premature birth, low birth weight, and developmental delays.

The causes of depressive disorders are complex and multifactorial. Some of the common causes of depression include genetic predisposition, chemical imbalances in the brain, and environmental factors such as stress, trauma, and substance abuse (Sheeba et al., 2019)Treatment Of Depression Disorder Essay Discussion Paper. During pregnancy, hormonal changes can also contribute to the development of depressive disorders. Specifically, the increased levels of estrogen and progesterone during pregnancy can impact neurotransmitter activity in the brain, leading to changes in mood, sleep, and appetite.

The symptoms of depressive disorders can vary widely and may include feelings of sadness, hopelessness, and worthlessness, as well as changes in appetite, sleep, and energy levels. Pregnant women may also experience physical symptoms such as nausea, headaches, and fatigue, which can further exacerbate feelings of depression. Additionally, pregnant women may experience anxiety about the health of their baby, financial concerns, or relationship issues, which can contribute to feelings of depression.

Diagnosing depression in pregnant women can be challenging, as some of the symptoms of depression can overlap with normal pregnancy symptoms. However, healthcare providers can use a combination of screening tools and clinical assessments to diagnose depressive disorders in pregnant women. Some of the screening tools commonly used include the Edinburgh Postnatal Depression Scale (EPDS) and the Patient Health Questionnaire (PHQ-9)Treatment Of Depression Disorder Essay Discussion Paper. In addition, healthcare providers may ask questions about the patient’s medical history, family history of depression, and current symptoms.

When it comes to treating depressive disorders in pregnant women, medication options can be limited due to the potential risks to the developing fetus. However, some medications may be considered safe to use during pregnancy if the benefits outweigh the risks. Healthcare providers must weigh the potential risks and benefits of medication treatment carefully. Selective Serotonin Reuptake Inhibitors (SSRIs) are a class of antidepressant medications that are commonly prescribed during pregnancy. They work by increasing levels of serotonin in the brain, which can improve mood and reduce symptoms of depression (Edinoff et al., 2021)Treatment Of Depression Disorder Essay Discussion Paper. However, some studies have suggested that exposure to SSRIs during pregnancy may be associated with an increased risk of preterm birth, low birth weight, and neonatal adaptation syndrome. Despite these risks, healthcare providers may still prescribe SSRIs if they determine that the benefits outweigh the risks for the individual patient. Common side effects of SSRIs include nausea, vomiting, diarrhea, and dizziness. Additionally, abrupt discontinuation of SSRIs can lead to withdrawal symptoms such as headaches, anxiety, and insomnia.

The FDA has approved several antidepressant medications for use during pregnancy, including fluoxetine (Prozac) and sertraline (Zoloft), both of which are SSRIs (Cipriani et al., 2018)Treatment Of Depression Disorder Essay Discussion Paper. However, it is important to note that FDA approval does not necessarily mean that a medication is completely safe to use during pregnancy. Healthcare providers must carefully weigh the potential risks and benefits of medication treatment for each individual patient.

ORDER HERE

When prescribing medication for depressive disorders in pregnant women, healthcare providers must consider the potential risks and benefits to both the mother and the developing fetus. They must also take into account the specific medication being prescribed and any relevant considerations associated with that medication, such as dosage and duration of treatment, potential medication interactions, and specific risks associated with certain medications. By carefully weighing these factors, healthcare providers can ensure that pregnant women with depressive disorders receive appropriate and safe treatment.

In regard to monitoring, healthcare providers must monitor the patient closely to ensure that the medication is working effectively and that no adverse effects are occurring. In addition to monitoring the patient’s mental health and well-being, healthcare providers may also need to monitor specific labs and comorbid medical issues. One of the important labs to monitor is the patient’s liver function, as some antidepressants can affect liver enzymes. If liver function becomes impaired, it can impact the metabolism and elimination of medication, potentially leading to toxicity or other adverse effects. Another important consideration is monitoring for comorbid medical issues, such as hypertension or diabetes, which can be common in pregnant women. Depression and comorbid medical conditions can exacerbate one another, and healthcare providers must monitor these conditions to ensure that treatment is effective and that both the mother and the developing fetus are healthy. Treatment Of Depression Disorder Essay Discussion Paper

In addition to considering the medical aspects of treating depressive disorders in pregnant women with medication, healthcare providers must also consider a variety of legal, ethical, cultural, and social determinants of health factors. Legal considerations may include ensuring that the medication prescribed is FDA-approved for use in pregnant women and that it is prescribed within the bounds of state and federal laws. Healthcare providers may also need to consider any potential liability issues that may arise from prescribing medication during pregnancy. Ethical considerations may include ensuring that the medication prescribed aligns with the patient’s values and preferences and that the risks and benefits of treatment are clearly communicated. Healthcare providers may also need to consider issues related to autonomy and informed consent, particularly in cases where the patient may not fully understand the risks and benefits of treatment.

Cultural considerations include taking into account the patient’s cultural background and beliefs when developing a treatment plan. For example, some cultural beliefs may discourage the use of medication during pregnancy, which can impact treatment decisions. Social determinants of health may also play a role in treatment decisions, as factors such as socioeconomic status, access to healthcare, and social support can impact the patient’s ability to receive and adhere to treatment.

Patients and their families can follow up with their healthcare provider or pharmacist for further information on treating depressive disorders during pregnancy. They can also consult local community resources, such as support groups or mental health clinics, for additional information and resources.Treatment Of Depression Disorder Essay Discussion Paper

Examples of how to write a proper prescription that I would provide to the patient or transmit to the pharmacy include:

1. Prescription for Sertraline 50mg tablets, take 1 tablet by mouth daily for treatment of depressive disorder during pregnancy. Dispense 30 tablets, with 2 refills.
2. Prescription for Bupropion 100mg sustained-release tablets, take 1 tablet by mouth twice daily for treatment of depressive disorder during pregnancy. Dispense 60 tablets, with no refills.
3. Prescription for Venlafaxine 75mg extended-release capsules, take 1 capsule by mouth daily for treatment of depressive disorder during pregnancy. Dispense 30 capsules, with 1 refill.

In recap, depression during pregnancy can be a challenging condition that requires careful consideration of risks and benefits when it comes to medication treatment. This patient medication guide provides valuable information on depressive disorders and medication treatment options for pregnant women, including screening tools, medication options, and monitoring considerations. While medication options may be limited due to potential risks to the developing fetus, healthcare providers can carefully weigh the potential risks and benefits of treatment and consider alternative options such as psychotherapy. By considering a variety of medical, legal, ethical, cultural, and social determinants of health factors, healthcare providers can ensure that pregnant women with depressive disorders receive appropriate and safe treatment that promotes the health and well-being of both the mother and the developing fetus.

ORDER NOW

References

Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., … & Geddes, J. R. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Focus, 16(4), 420-429.

Edinoff, A. N., Akuly, H. A., Hanna, T. A., Ochoa, C. O., Patti, S. J., Ghaffar, Y. A., … & Kaye, A. M. (2021). Selective serotonin reuptake inhibitors and adverse effects: a narrative review. Neurology International, 13(3), 387-401.

Sheeba, B., Nath, A., Metgud, C. S., Krishna, M., Venkatesh, S., Vindhya, J., & Murthy, G. V. S. (2019). Prenatal depression and its associated risk factors among pregnant women in Bangalore: a hospital based prevalence study. Frontiers in public health, 7, 108 Treatment Of Depression Disorder Essay Discussion Paper